- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/07 - Bacillus
Patent holdings for IPC class A61K 39/07
Total number of patents in this class: 292
10-year publication summary
|
25
|
24
|
16
|
14
|
15
|
12
|
12
|
15
|
13
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20355 |
10 |
| Bayer Cropscience LP | 359 |
7 |
| The Regents of the University of Michigan | 4836 |
7 |
| Altimmune Inc | 23 |
7 |
| Spogen Biotech Inc. | 144 |
7 |
| The Trustees of the University of Pennsylvania | 4382 |
5 |
| Horizon Technology Finance Corporation | 23 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2942 |
5 |
| Himv LLC | 24 |
5 |
| President and Fellows of Harvard College | 6049 |
4 |
| The Johns Hopkins University | 5772 |
3 |
| Dynavax Technologies Corporation | 119 |
3 |
| Emergent BioSolutions Inc. | 33 |
3 |
| Ganeden Biotech, Inc. | 55 |
3 |
| Molecular Express, Inc. | 14 |
3 |
| PharmAthene, Inc. | 10 |
3 |
| Phico Therapeutics Ltd. | 19 |
3 |
| Soligenix, Inc. | 49 |
3 |
| The Texas a & M University System | 1799 |
3 |
| Texas Tech University System | 619 |
3 |
| Other owners | 200 |